Biopreservation Market by End-user, Application, and Geography - Forecast and analysis of 2023-2027

Published: Oct 2023 Pages: 153 SKU: IRTNTR75718

Biopreservation Market Forecast 2023-2027

The biopreservation market size is estimated to grow by USD 2.40 billion at a Compound annual growth rate (CAGR) of 15.88% between 2022 and 2027. The market is fueled by the escalating demand for personalized medicine, a surge in the number of biobanks, and the global rise in chronic diseases. As personalized medicine gains traction, biobanks are expanding to store diverse biological samples. Additionally, the prevalence of chronic diseases worldwide necessitates efficient storage and preservation of biological specimens for research and treatment, driving the market forward.

What will be the size of the Market During the Forecast Period?

To learn more about this report, View Report Sample

 

Market Segmentation

This market growth analysis report extensively covers market segmentation by end-user (life sciences and healthcare facilities, research laboratories, and others), application (biobanks, regenerative medicine, and drug discovery), and geography (North America, Asia, Europe, and Rest of World (ROW)).

By End-User

The life science and healthcare facilities segment is estimated to witness significant growth during the forecast period. The key factor that drives the growth of the life sciences and healthcare facilities segment is the growing prevalence of obesity and chronic diseases globally. The rising number of patients diagnosed with chronic diseases, such as cardiac ailments, diabetes, and degenerative conditions affecting the nerves, bones, and joints, is driving the demand for biopreservation in the life sciences and healthcare facilities segment. 

Get a glance at the market contribution of various segments View the PDF Sample

The life science and healthcare facilities segment was the largest segment and was valued at  USD 697.02 million in 2017. A major shortage of donors for organ transplants has increased the demand for regenerative medicine all over the world. Regenerative medicine is used for treating and controlling various degenerative conditions and chronic diseases. Regenerative medicine broadly requires biopreservation techniques to keep the functionality and integrity of cells, tissues, or organs undamaged. The growing usage of regenerative medicines is directly increasing the demand for biopreservation, which thereby will drive the growth of the life sciences and healthcare facilities segment of the market during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, biopreservation has emerged as an important feature of the research landscape over the past 15 years. Increasing funding from healthcare organizations, such as the National Institutes of Health (NIH), has fueled market growth in the region. The NIH continues to be the major source of funding and facilitator for biopreservation in the US. It is also focused on the biopreservation efforts in major healthcare institutions, such as the National Cancer Institute.

Market Dynamics and Customer Landscape

The market is experiencing robust growth. Hospitals, labs, and government entities, along with private partners, are investing heavily in healthcare research & development and product development. Leading companies like BioLife Solutions are pioneering advancements in controlled freezer technology to cater to the expanding cell and gene therapy market. This technology ensures the preservation of vital biological materials such as stem cells, DNA, tissues, and organs in their natural environment. Innovative solutions like microarrays, predictive models, and hybrid models powered by API algorithms enable efficient diagnostic and treatment measures, particularly in cardiology, gynecology, and point-of-care applications.

Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The surging demand for personalized medicine is propelling market expansion. Meeting the substantial medical need to devise effective therapies for various diseases has spurred the requirement for personalized medicine, thus escalating the necessity for biopreservation. In this landscape, market players may find themselves in a transformative position. Personalized medicine tailors treatments to individual needs and preferences, prompting individuals to increasingly bank their tissues and stem cells for potential future treatments.

Crucially, personalized medicine relies on the availability of individual samples with annotated clinical and pathological data. Research institutions are currently exploring the potential of developing personalized treatments using biosamples. Biobanking, a form of biopreservation, significantly contributes to personalized medicine and genomics research. Consequently, the rising demand for personalized medicine is set to drive global demand for biopreservation, fostering market growth.

Significant Market Trends

The emergence of stem cell storage in biobanks is a primary trend in the market. The demand for stem cell storage in biobanks is growing phenomenally and is expected to have a positive impact on the growth of the market during the forecast period. In areas like cardiology and oncology, scientists believe stem cells have the potential to respond to a wide range of needs that are not met. Therefore, the market is witnessing many new biobanking facilities that are particularly dedicated to stem cell research. 

Moreover, research organizations are focusing on establishing advanced production or manufacturing units to improve supply chain efficiency, thereby boosting production capacities. For example, the adoption of IT in logistics to ease the monitoring of biobanking services and the development of temperature-controlled logistics solutions, such as cryopreservation, will help minimize manual errors besides producing large batches of stem cell therapy products in a closed, sterile environment. Such factors are likely to lead to substantial growth opportunities for the market during the forecast period.

Major Market Challenge

Ethical issues are a major challenge in a market. Issues regarding privacy while accessing biological samples remain a major ethical issue with biopreservation, where protecting the identity of individuals is a major concern. The first step in the process of protection is the need for informed consent. Moreover, for private companies active on the market, the use of biobank information could be attempted in their own interests. Ethical questions concerning the preservation of biological samples have been under constant discussion for many years. In a number of countries, research carried out in the field of biological specimens like tissues and stem cells is also disputed.

Some of the ethical issues worth mentioning here include the cloning of embryonic stem cells and the destruction of embryos to create cell lines. Moreover, there is still a debate on safety concerns, scientific purity, and acceptance of the use of Human Embryo Stem Cell Lines in research. These factors may act as a hindrance to the growth of the market during the forecast period.

Customer Landscape

The market research and growth report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Who are the Major Biopreservation Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AMS Biotechnology Europe Ltd. - The company offers biopreservation such as AMSbio CryoStor.

The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including: 

  • ARCTIKO AS
  • Avantor Inc.
  • Bio Techne Corp.
  • BioLife Solutions Inc.
  • Chart Industries Inc.
  • Exact Sciences Corp.
  • IC Biomedical LLC
  • Merck KGaA
  • NIPPON Genetics Europe GmbH
  • OPS Diagnostics LLC
  • PHC Holdings Corp.
  • QIAGEN NV
  • Shanghai Genext Medical Technology Co. Ltd.
  • So Low Environmental Equipment Co. Inc.

Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market serves a crucial role across various sectors, including hospitals, labs, and government entities, often collaborating with private partners for research and development initiatives. It supports product development by providing controlled freezing environments for the storage of biological specimens essential for advancing cell and gene therapies, DNA research, and understanding disease progression. With ongoing technological innovations like microarrays and predictive models, biopreservation addresses challenges such as time, cost, and complexity in diagnostic and treatment measures. It caters to diverse applications, from gynecology to immunotherapies, vaccine production, and enzyme technology, combating health disorders like cardiovascular diseases. Government and private sectors, along with investors, contribute to healthcare spending, supporting skilled labor and cybersecurity measures to ensure data integrity and patient safety.

The market is witnessing significant advancements in research and development, particularly in technologies like controlled freezers and hybrid models, catering to the burgeoning cell and gene therapy market. With a focus on preserving biological samples in their natural environment, innovative solutions like API algorithms and multiplex cellular imaging platforms are emerging. These technologies facilitate diagnostic and treatment measures, especially in point-of-care applications and antibody production. Moreover, biopreservation supports the production of biologically produced chemicals, crucial in combating chronic diseases like cardiovascular disorders. Government sectors are collaborating to address rising chronic disease incidences, emphasizing skilled professional training and software standardization to optimize equipment efficiency across plasma, tissue culture, and media applications, ensuring reliable research data.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user Outlook 
    • Life sciences and healthcare facilities
    • Research laboratories
    • Others
  • Application Outlook 
    • Biobanks
    • Regenerative medicine
    • Drug discovery
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Antarctica
      • Rest of the world 

 

Biopreservation Market Scope

Report Coverage

Details

Page number

153

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 15.88%

Market growth 2023-2027

USD 2.40 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

15.34

Regional analysis

North America, Asia, Europe, and Rest of the World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

AMS Biotechnology Europe Ltd., ARCTIKO AS, Avantor Inc., Bio Techne Corp., BioLife Solutions Inc., Chart Industries Inc., Exact Sciences Corp., IC Biomedical LLC, Merck KGaA, NIPPON Genetics Europe GmbH, OPS Diagnostics LLC, PHC Holdings Corp., QIAGEN NV, Shanghai Genext Medical Technology Co. Ltd., So Low Environmental Equipment Co. Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., ThermoGenesis Holdings Inc., Thomas Scientific LLC, and Trane Technologies Plc

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Asia, Europe, and the Rest of the World (ROW)
  • Through analysis of the market’s competitive landscape and detailed information about Companies
  • Comprehensive analysis of factors that will challenge the growth of market Companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global biopreservation market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global biopreservation market 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Life sciences and healthcare facilities - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Life sciences and healthcare facilities - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Life sciences and healthcare facilities - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Life sciences and healthcare facilities - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Life sciences and healthcare facilities - Year-over-year growth 2022-2027 (%)
    • 6.4 Research laboratories - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Research laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Research laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Research laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Research laboratories - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 48: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 50: Chart on Comparison by Application
      • Exhibit 51: Data Table on Comparison by Application
    • 7.3 Biobanks - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Biobanks - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Biobanks - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Biobanks - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Biobanks - Year-over-year growth 2022-2027 (%)
    • 7.4 Regenerative medicine - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Regenerative medicine - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Regenerative medicine - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Regenerative medicine - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Regenerative medicine - Year-over-year growth 2022-2027 (%)
    • 7.5 Drug discovery - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Application
      • Exhibit 64: Market opportunity by Application ($ million)
      • Exhibit 65: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 Japan - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.11 France - Market size and forecast 2022-2027
      • Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 AMS Biotechnology Europe Ltd.
              • Exhibit 115: AMS Biotechnology Europe Ltd. - Overview
              • Exhibit 116: AMS Biotechnology Europe Ltd. - Product / Service
              • Exhibit 117: AMS Biotechnology Europe Ltd. - Key offerings
            • 12.4 Avantor Inc.
              • Exhibit 118: Avantor Inc. - Overview
              • Exhibit 119: Avantor Inc. - Business segments
              • Exhibit 120: Avantor Inc. - Key offerings
              • Exhibit 121: Avantor Inc. - Segment focus
            • 12.5 Bio Techne Corp.
              • Exhibit 122: Bio Techne Corp. - Overview
              • Exhibit 123: Bio Techne Corp. - Business segments
              • Exhibit 124: Bio Techne Corp. - Key news
              • Exhibit 125: Bio Techne Corp. - Key offerings
              • Exhibit 126: Bio Techne Corp. - Segment focus
            • 12.6 BioLife Solutions Inc.
              • Exhibit 127: BioLife Solutions Inc. - Overview
              • Exhibit 128: BioLife Solutions Inc. - Product / Service
              • Exhibit 129: BioLife Solutions Inc. - Key offerings
            • 12.7 Chart Industries Inc.
              • Exhibit 130: Chart Industries Inc. - Overview
              • Exhibit 131: Chart Industries Inc. - Business segments
              • Exhibit 132: Chart Industries Inc. - Key news
              • Exhibit 133: Chart Industries Inc. - Key offerings
              • Exhibit 134: Chart Industries Inc. - Segment focus
            • 12.8 Exact Sciences Corp.
              • Exhibit 135: Exact Sciences Corp. - Overview
              • Exhibit 136: Exact Sciences Corp. - Product / Service
              • Exhibit 137: Exact Sciences Corp. - Key offerings
            • 12.9 IC Biomedical LLC
              • Exhibit 138: IC Biomedical LLC - Overview
              • Exhibit 139: IC Biomedical LLC - Product / Service
              • Exhibit 140: IC Biomedical LLC - Key offerings
            • 12.10 Merck KGaA
              • Exhibit 141: Merck KGaA - Overview
              • Exhibit 142: Merck KGaA - Business segments
              • Exhibit 143: Merck KGaA - Key news
              • Exhibit 144: Merck KGaA - Key offerings
              • Exhibit 145: Merck KGaA - Segment focus
            • 12.11 NIPPON Genetics EUROPE GmbH
              • Exhibit 146: NIPPON Genetics EUROPE GmbH - Overview
              • Exhibit 147: NIPPON Genetics EUROPE GmbH - Product / Service
              • Exhibit 148: NIPPON Genetics EUROPE GmbH - Key offerings
            • 12.12 PHC Holdings Corp.
              • Exhibit 149: PHC Holdings Corp. - Overview
              • Exhibit 150: PHC Holdings Corp. - Business segments
              • Exhibit 151: PHC Holdings Corp. - Key offerings
              • Exhibit 152: PHC Holdings Corp. - Segment focus
            • 12.13 QIAGEN NV
              • Exhibit 153: QIAGEN NV - Overview
              • Exhibit 154: QIAGEN NV - Product / Service
              • Exhibit 155: QIAGEN NV - Key news
              • Exhibit 156: QIAGEN NV - Key offerings
            • 12.14 STEMCELL Technologies Inc.
              • Exhibit 157: STEMCELL Technologies Inc. - Overview
              • Exhibit 158: STEMCELL Technologies Inc. - Product / Service
              • Exhibit 159: STEMCELL Technologies Inc. - Key offerings
            • 12.15 Thermo Fisher Scientific Inc.
              • Exhibit 160: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 161: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 162: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 163: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 164: Thermo Fisher Scientific Inc. - Segment focus
            • 12.16 ThermoGenesis Holdings Inc.
              • Exhibit 165: ThermoGenesis Holdings Inc. - Overview
              • Exhibit 166: ThermoGenesis Holdings Inc. - Product / Service
              • Exhibit 167: ThermoGenesis Holdings Inc. - Key offerings
            • 12.17 Trane Technologies Plc
              • Exhibit 168: Trane Technologies Plc - Overview
              • Exhibit 169: Trane Technologies Plc - Business segments
              • Exhibit 170: Trane Technologies Plc - Key news
              • Exhibit 171: Trane Technologies Plc - Key offerings
              • Exhibit 172: Trane Technologies Plc - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 173: Inclusions checklist
                • Exhibit 174: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 175: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 176: Research methodology
                • Exhibit 177: Validation techniques employed for market sizing
                • Exhibit 178: Information sources
              • 13.5 List of abbreviations
                • Exhibit 179: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              biopreservation market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis